Evidence map›Paper›PMID 31300703›Full record

ArticleScientific reports2019

Neutrophil-derived miR-223 as local biomarker of bacterial peritonitis.

Amy C Brook, Robert H Jenkins, Aled Clayton, Ann Kift-Morgan, Anne-Catherine Raby, Alex P Shephard, Barbara Mariotti, Simone M Cuff, Flavia Bazzoni, Timothy Bowen and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Technical and Methodological Aspects of Cell-Free Nucleic Acids Analyzes.International journal of molecular sciences · 2020
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Amy C BrookDivision of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, United Kingdom.ORCID http://orcid.org/0000-0001-8374-2218
Robert H JenkinsDivision of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, United Kingdom.
Aled ClaytonDivision of Cancer and Genetics, School of Medicine, Cardiff University, Cardiff, United Kingdom.
Ann Kift-MorganDivision of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, United Kingdom.
Anne-Catherine RabyDivision of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, United Kingdom.
Alex P ShephardDivision of Cancer and Genetics, School of Medicine, Cardiff University, Cardiff, United Kingdom.
Barbara MariottiDepartment of Medicine, Section of General Pathology, University of Verona, Verona, Italy.
Simone M CuffDivision of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, United Kingdom.
Flavia BazzoniDepartment of Medicine, Section of General Pathology, University of Verona, Verona, Italy.ORCID http://orcid.org/0000-0001-6768-8012
Timothy BowenDivision of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, United Kingdom.ORCID http://orcid.org/0000-0001-6050-0435
Donald J FraserDivision of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, United Kingdom.
Matthias EberlDivision of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, United Kingdom. eberlm@cf.ac.uk.ORCID http://orcid.org/0000-0002-9390-5348
Cardiff University · GBKidney Research UK · GBUniversity of Verona · ITCardiff and Vale University Health Board · GB

Funding

Department of Health II-LA-0712-20003Department of Health II-LA-0712-20006Medical Research Council MR/N023145/1
6 · The paper itself

Abstract

Infection remains a major cause of morbidity, mortality and technique failure in patients with end stage kidney failure who receive peritoneal dialysis (PD). Recent research suggests that the early inflammatory response at the site of infection carries diagnostically relevant information, suggesting that organ and pathogen-specific "immune fingerprints" may guide targeted treatment decisions and allow patient stratification and risk prediction at the point of care. Here, we recorded microRNA profiles in the PD effluent of patients presenting with symptoms of acute peritonitis and show that elevated peritoneal miR-223 and reduced miR-31 levels were useful predictors of bacterial infection. Cell culture experiments indicated that miR-223 was predominantly produced by infiltrating immune cells (neutrophils, monocytes), while miR-31 was mainly derived from the local tissue (mesothelial cells, fibroblasts). miR-223 was found to be functionally stabilised in PD effluent from peritonitis patients, with a proportion likely to be incorporated into neutrophil-derived exosomes. Our study demonstrates that microRNAs are useful biomarkers of bacterial infection in PD-related peritonitis and have the potential to contribute to disease-specific immune fingerprints. Exosome-encapsulated microRNAs may have a functional role in intercellular communication between immune cells responding to the infection and the local tissue, to help clear the infection, resolve the inflammation and restore homeostasis.

Indexed as

AdultAgedAged, 80 and overAnimalsBacterial InfectionsCross-Sectional StudiesEscherichia coli InfectionsExtracellular VesiclesFemaleGenetic MarkersGram-Negative Bacterial InfectionsHumansMaleMice, Inbred C57BLMicroRNAsMiddle AgedGenetic MarkersMicroRNAsMIR223, human

Identifiers

PMID31300703
PMCPMC6625975
OpenAlexW2958559323

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.